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paraventricular nucleus regulate genital responses and copulation in male rats. PHARMACOL BIOCHEM BEHAV 39(1)  177- 
181,  1991.--The D2 dopamine receptor agonist quinelorane (LY-163502),  microinjected  into the paraventricular nucleus (PVN), 
affected  genital responses of restrained supine male rats in a biphasic dose-dependent  fashion. A moderate  dose (1  Ixg) facilitated 
penile  responses  (intense erections  and  penile  movements),  and  decreased  the  latency  to  the  first response.  A  high dose  of 
quinelorane (10 Ixg) facilitated seminal emission while inhibiting penile responses.  The addition of the D1  antagonist SCH-23390 
to the 1 ixg dose of quinelorane potentiated quinelorane's increase  in seminal emission.  We suggest that D1  receptors  in the PVN 
may  be  antagonistic to  D2  receptor-mediated seminal emission,  and possibly  also  penile  responses.  In  copulation  tests  1  ~g 
quinelorane decreased mount latency, whereas  10 ixg quinelorane increased mount and intromission latencies  and slowed  copula- 
tory rate.  Both  1 and  10  Ixg quinelorane,  and also  1 and  10  Ixg of the mixed D1  and D2  agonist apomorphine, decreased  the 
number of intromissions preceding ejaculation. 
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STIMULATION  of  dopamine  receptors  in  the  paraventricular 
nucleus  (PVN)  was  reported  by  Melis  et  al.  to  increase  penile 
erection  and  yawning  in  freely  moving  male  rats  (6).  In  those 
studies,  LY-171555,  a  specific  D2  receptor agonist,  was  as  ef- 
fective  as  the  mixed  D1  and  D2  agonist  apomorphine  in  in- 
creasing  penile  erections  and  yawning  when  injected  into  the 
PVN.  Furthermore,  facilitation by apomorphine was blocked by 
both the D2  antagonist haloperidol and the D1  antagonist SCH- 
23390.  Melis et al.  suggested that D2  receptors  in the PVN fa- 
cilitate  erections,  and  that  DI  receptors  "enable"  the  D2- 
mediated  response. 
We  have  recently  examined  the  effects  of  medial  preoptic 
area  (MPOA)  injections  of  the  D2  agonist  quinelorane 
(LY-163502)  on  genital  responses  in  restrained  supine  rats  (2) 
and  also  on  copulation  (5).  A  high  dose  of quinelorane  in  the 
MPOA facilitated seminal emission while inhibiting penile erec- 
tions.  In  copulation  tests the  same  dose  of quinelorane delayed 
the  onset of copulation  and  slowed  its rate,  but  also  decreased 
the  number  of  intromissions  preceding  ejaculation.  We  sug- 
gested that the delay in copulatory onset may have been related 
to  an impairment of erectile  mechanisms,  whereas  the  decrease 
in intromissions preceding ejaculation may have reflected an en- 
hancement of seminal emission (5). 
The present experiments extended our study of quinelorane's 
effects on sexual behavior to the PVN.  Genital responses of re- 
strained  supine  rats  were  observed  following  a  wide  range  of 
doses  of quinelorane.  In  addition,  the effects of quinelorane on 
copulation  were  compared  with  effects  of  the  mixed  agonist 
apomorphine. 
METHOD 
Animals 
For  each  experiment  twenty  adult  male  Long-Evans  rats 
weighing  300-375  g  were  housed  individually  in  large  plastic 
cages.  A  14:10 light:dark cycle  was  in effect,  with lights off at 
11.00  h.  Food  and  water  were  available ad  lib.  Animals  were 
handled daily so that microinjection could be performed without 
anesthesia.  Data  from  animals  that  failed  to  exhibit genital  re- 
sponses on two  or more  tests in Experiment  1,  or that failed to 
copulate  on  two  or  more  tests  in  Experiment  2,  were  removed 
from statistical analysis.  Data were  also removed if an animal's 
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cannula was located further than 0.5 mm from the PVN. 
Surgery and Cannulae 
The male rats were anesthetized with ketamine hydrochloride 
(50  mg/kg)  and  xylazine hydrochloride  (4 mg/kg).  Each  animal 
received  a  23-ga  thin  wall  unilateral  stainless  steel  guide  can- 
nula directed  to end  1 mm above the PVN  [AP,  0.4;  ML,  0.4; 
DV,  -7.0;  incisor bar,  + 5  mm; (8)].  Guide cannulae were im- 
planted  using  a  Kopf stereotaxic  frame.  Details  of surgery  and 
cannula construction are described in Hull et al.  (4).  An obtura- 
tor  fashioned  from  27-ga  stainless  steel  tubing  prevented  entry 
of foreign material and kept the guide cannula patent.  It was cut 
to end even with the guide cannula,  and held in place by a  col- 
lar constructed  of 23-ga stainless  steel tubing  and  polyethylene. 
An  injection  cannula,  used  at  the  time  of drug  administration, 
was  constructed  of 27  ga  stainless  steel tubing  and  extended  1 
mm beyond the guide cannula. 
For Experiment  2,  female rats  of the  same  strain  were  ova- 
riectomized under ketamine  and  xylazine anesthesia.  They were 
housed in a  separate room,  and were brought into behavioral es- 
trus  by  an  injection of 20  Ixg estradiol  benzoate  (Sigma)  in  oil 
SC 48 h  before behavioral testing. 
Drugs 
Quinelorane  (LY-163502)  was  donated  by  Dr.  Mark  Fore- 
man,  Eli Lilly and Company (Indianapolis,  IN) and dissolved in 
sterile water immediately before administration.  SCH-23390 was 
donated  by  Dr.  Allen  Barnett,  Schering  Corporation  (Bloom- 
field, NJ) and was dissolved in  10% dimethyl sulfoxide (DMSO) 
and  sterile  water  prior to  administration.  Apomorphine  (Sigma) 
was dissolved in sterile water with 0.2%  ascorbate. 
Procedures 
Experiment  1.  Prior  to  surgery,  males  were  adapted  to  the 
restrainer  and  then  given 3  screening tests  for penile responses. 
Males that displayed responses on 2 of the 3 screening tests were 
used in the experiment. A  postoperative baseline was established 
one  week  after  surgery.  Thereafter,  behavioral  tests  following 
drug  (0.1,  1  and  10  txg  quinelorane)  or  vehicle administration 
were given at one-week intervals.  All animals received all doses 
in  counterbalanced  order.  On the fifth week of testing,  all ani- 
mals received 1 Ixg quinelorane plus 5  Ixg SCH-23390. 
At  the  time  of testing,  the  obturator  was  removed  and  the 
injection cannula was inserted.  The injection volume was 0.5  Ixl 
and  was  delivered  at  a  rate  of  1  txl/min.  The  injection cannula 
was  left in place  for  30  s  after  the  injection to  maximize drug 
diffusion  into  surrounding  tissue.  The  obturator  was  replaced, 
and  the  male was  carried  to an  adjacent testing  chamber  where 
testing began immediately. 
During behavioral testing, each rat was placed in a  metal re- 
strainer  (8.5 x 5.5 x20  cm)  in  the  supine  position  and  held  in 
place by Velcro straps.  The lower portion of the rat's body was 
left exposed.  The penile sheath  was retracted  and  maintained in 
that  position  to  elicit  penile  responses.  Spontaneous  responses 
usually  occured  within  10  minutes  after  exposure  of the  glans. 
Responses occurred within clusters,  separated  by  15  s or longer 
of inactivity. Three gradations of erections were scored:  El, en- 
gorgement  of these  base  of the  glans;  E2,  tumescence  of both 
the  base  and  tip  of the  glans;  E3,  tumescence  of the  base  ac- 
companied by extreme flaring of the tip of the glans (sometimes 
called a  cup).  Two grades  of penile movements  (anteroflexions 
of the penis,  sometimes called flips) were  scored:  short,  antero- 
flexions that  did not pass  vertical in relation to the body;  long, 
anteroflexions  that  passed  the  vertical.  Seminal  emission  was 
scored by the presence of viscous seminal fluid or a  sperm plug. 
A  test lasted  15  minutes  from the first penile response  (i.e., 
erection or penile movement),  or 20 minutes  if no response  oc- 
curred.  The  time  and  number  of each  type  of erection,  penile 
movement and  seminal emission were recorded using  a program 
written by Stephen Yeoh for the IBM microcomputer.  Measures 
derived from the data were the latency to the first response,  the 
number  of clusters,  the  number  of seminal  emissions,  the  total 
number  of  responses,  the  total  number  of  erections,  the  total 
number  of penile  movements  and  the  number  of each  grade  of 
erection (El, E2, E3) and penile movement (short,  long). 
Experiment  2.  Males  were  given  sexual  experience  in  their 
home  cage  for  two  30-min  periods.  Copulatory  measures  were 
then  scored on a  preoperative baseline  test.  Two weeks  follow- 
ing  surgery,  they  were  given  a  postoperative  test.  Thereafter, 
they  were  given  weekly  tests  following counterbalanced  injec- 
tions  of  vehicle,  1  and  10  Ixg  quinelorane,  and  1  and  10  txg 
apomorphine.  Injection procedures  were the same as for Experi- 
ment  1. 
Animals were carried to an adjacent room, where a receptive 
female  was  placed  into each  male's  home  cage.  Testing  began 
immediately. Each test lasted for 30 min after the first intromis- 
sion,  or for a  total of 30 min if the male failed to intromit.  The 
occurrence and time of each mount,  intromission and ejaculation 
were  recorded  by  a  program  written  by  Stephen  Yeoh  for  the 
IBM  microcomputer.  Measures  derived  from  the  data  were: 
number  of ejaculations  per  test,  numbers  of mounts  and  of in- 
tromissions  preceding  each  ejaculation,  latencies  to  the  first 
mount  and  the  first  intromission,  ejaculation  latency  (latency 
from the first  intromission of an ejaculatory series to the  subse- 
quent  ejaculation),  postejaculatory  refractory  period  (time  from 
the ejaculation to the next intromission),  interintromission  inter- 
val  (the  average  time  between  intromissions),  and  intromission 
ratio (number of intromissions divided by mounts plus  intromis- 
sions). Intromissions were distinguished behaviorally from mounts 
by the presence  of a  deep thrust  followed by  a  rapid,  springing 
dismount.  Ejaculation  patterns  were  characterized  by  longer, 
deeper  thrusts,  slow  dismounts  and  a  prolonged  period  of rest 
after ejaculation. 
Statistical Analysis 
A  counterbalanced,  repeated measures design was used.  Data 
were  analyzed  by  one-way  repeated  measures  analyses  of vari- 
ance, followed by Dunnett's t-statistic comparing treatment means 
with the control (9).  All data are presented as mean-4-SEM. 
Histology 
After all behavioral testing, males were anesthetized and sac- 
rificed by decapitation.  Cannulae were removed and brains were 
frozen  in  an  American Optical  cryostat.  Coronal  sections  were 
cut  at  40  txm,  mounted  on  glass  slides  and  stained  with cresyl 
violet.  Sections  were  examined  with  a  projection  magnifier  to 
verify  cannula  placement.  Data  from  animals  whose  cannulae 
were more than 0.5 mm from the PVN were excluded. 
RESULTS 
Experiment  1 
Intra-PVN injection of quinelorane affected genital responses 
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FIG.  1.  Effects  of  intracranial administration of  vehicle,  quinelorane 
(0.1  Q,  1 Q  and 10 Q) and the combined treatment of quinelorane and 
SCH-23390  (Q + S) on the latency (seconds)  to the first penile response. 
Data are  expressed as mean_SEM.  *p<0.05,  **p<0.01.  Q=quinelo- 
rane; Q + S = quinelorane (1  p.g)  + SCH 23390  (5 Ixg). 
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FIG.  3.  Effects  of  intracranial  administration of  vehicle,  quinelorane 
(0.1  Q,  1 Q and 10 Q) and the combined treatment of quinelorane and 
SCH-23390  (Q+S)  on  total  erections.  Data  are  expressed  as 
mean-+SEM.  *p<0.05.  Q=quinelorane  (v,g);  Q+S=quinelorane  (1 
v.g)  +  SCH 23390  (5 p.g). 
quinelorane, as well as the combined treatment of 1 Ixg quinelo- 
rane plus 5  ~g SCH-23390,  decreased the time to the first geni- 
tal  response  [F(4,76)=3.85,  p<0.01;  see  Fig.  1].  The  1  Ixg 
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dose increased the numbers of intense erections (E3)  [F(4,76)= 
2.96,  p<0.05;  see  Fig.  2a]  and  long  penile  movements 
[F(4,76)=2.62,  p<0.05;  see  Fig.  2b].  On  the  other  hand,  10 
Ixg  quinelorane  decreased  the  total  number  of  erections 
[F(4,76)=2.32,  p<0.06;  t(5,76)=2.26,  p<0.05;  see  Fig.  3]. 
The  10  p~g  dose  and  the  combined treatment increased  seminal 
emissions [F(4,76)=2.91,  p<0.05;  see Fig.  4]. 
Experiment 2 
Quinelorane  in  the  PVN  produced  dose-related  effects  on 
mount,  F(4,32)=5.29,  p<0.005,  and  intromission,  F(4,32)= 
3.17,  p<0.05,  latencies  and  on  interintromission  interval 
[F(4,32)=2.93,  p<0.05;  see Table  1].  The low dose  (1  Ixg)  of 
quinelorane decreased mount latency, whereas the high dose (10 
p,g)  of quinelorane  increased  mount  and  intromission  latencies 
and increased  interintromission interval.  In addition,  both doses 
of quinelorane and of apomorphine decreased the number of in- 
tromissions  preceding  ejaculation  [F(4,32)=4.09,  p<0.01;  see 
Table  1]. 
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FIG.  2.  Mean number of (A)  intense erections and (B) penile move- 
ments following intracranial administration of vehicle, quinelorane (0.1 
Q,  1 Q and 10 Q) and the combined treatment of quinelorane and SCH- 
23390  (Q+S).  Data  are  expressed  as  mean ___ SEM.  *p<0.05. 
Q = quinelorane (p,g); Q + S = quinelorane (1 Ixg) +  SCH 23390  (5 Ixg). 
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FIG.  4.  Effects  of  intracranial administration of  vehicle,  quinelorane 
(0.1  Q,  1 Q and 10 Q) and the combined treatment of quinelorane and 
SCH-23390  (Q+S)  on  seminal  emission.  Data  are  expressed  as 
mean-+SEM.  *p<0.05,  **p<0.01.  Q=quinelorane  (wg);  Q+S= 
quinelorane  (1  p.g)  +  SCH 23390  (5 txg). 180  EATON ET AL. 
TABLE 1 
EFFECTS OF QUINELORANE OR APOMORPHINE IN PVN ON COPULATION 
Veh  1 P-g LY  10 ixg LY  1 p.g APO  10 ~g APO 
Mount Latency  136.8  75.6*  424.2*  145.0  202.7 
(s)  ±28.4  ±27.1  +--128.0  +-_25.0  _+59.3 
Intromission Latency  267.8  176.0  653.3*  379.6  389.2 
(s)  _+78.2  _+71.9  _+ 125.6  _+ 129.5  _+ 128.4 
Intromissions per  9.7  6.6*  5.4t  7.1 *  6.3* 
Ejaculation  ± 1.5  _+0.8  _+0.5  _+0.7  _+0.6 
Interintromission  59.0  75.1  85.1"  47.8  48.1 
Interval (s)  _+8.5  -- 18.7  --- 12.0  ---5.1  -+4.4 
Ejaculation Latency  534.7  443.3  398.0  330.1  285.9 
(s)  ---87.7  _+89.2  -+46.2  ±23.5  ±21.5 
Total Ejaculations  1.9  2.0  2.4  2.2  2.0 
_+0.2  _+0.2  -+0.2  ---0.3  -+0.4 
Data expressed as mean  --- SEM.  *p<0.05,  tp<0.01. 
DISCUSSION 
Microinjection of quinelorane  into  the  PVN  affected  genital 
responses  in  a  dose-dependent  fashion.  A  facilitation  of penile 
responses by the  1 Ixg dose was  apparent  in the increased num- 
bers of intense erections and  long penile movements,  as well as 
in  the  decreased  latency  to  the  first  genital  response.  The  0.1 
p,g  dose  and  the  combination  of  1  ~g  quinelorane  and  5  ixg 
SCH-23390  also  decreased  the  latency  to  the  first  genital  re- 
sponse.  On  the  other  hand,  10  p,g  quinelorane  decreased  total 
erections  but  increased  the  number  of  seminal  emissions.  The 
0.1  i~g and  1  Ixg doses  of quinelorane  did  not  significantly af- 
fect  seminal  emission;  however,  the  addition  of  5  Ixg  SCH- 
23390  to  the  ineffective  1  Ixg dose  did  facilitate  seminal  emis- 
sion.  Thus  blocking D1  receptors  enhanced  the effectiveness of 
the D2  agonist,  suggesting  opposing  effects of the two receptor 
subtypes on seminal emission. 
Previous  studies  have  not  tested  higher  doses  of dopamine 
agonists  in  the  PVN.  Thus  the  biphasic  nature  of the  dose-re- 
sponse curve for genital responses  (facilitation by  1 txg quinelo- 
rane and impairment by 10 Ixg) has not been observed previously. 
It is, however,  somewhat similar to the dose-response curve that 
we observed with apomorphine or quinelorane in the MPOA (1, 
2,  7).  Specifically, low doses  increased  (apomorphine)  or failed 
to affect (quinelorane) the number of erections and penile move- 
ments;  low  doses  of  both  agonists  decreased  the  response  la- 
tency.  On  the  other  hand,  10  ~g  of  either  apomorphine  or 
quinelorane in the MPOA shifted the balance of responses to fa- 
vor seminal emission, and inhibit erection. 
The  dose  dependency  of quinelorane's  effects  was  also  ob- 
served in copulation tests.  The low dose (1  Ixg) in the PVN fa- 
cilitated  the  onset  of  copulation,  whereas  the  high  dose  both 
delayed  its  onset  and  slowed  copulatory  rate  (increased  inter- 
intromission interval). The shorter mount latency following 1 &g 
quinelorane  may  have  been  related  to  enhanced  processing  of 
sensorimotor  information,  since  the  same  dose  increased  the 
numbers of penile responses  in Experiment  1.  Similarly, the de- 
layed  onset  and  slowed  rate  observed  after  10  ~g  quinelorane 
may have reflected a  shift from erectile processes (mediated pri- 
marily by parasympathetic  and  striated muscle mechanisms)  and 
towards  seminal emission (sympathetically mediated)  and ejacu- 
latory processes. 
Whereas  the  latency measures  of copulation and  numbers  of 
ex  copula  penile  responses  appear  to  be  affected  similarly,  the 
decrease  in  intromissions  preceding  ejaculation  observed  after 
both  quinelorane  and  apomorphine  may  have  been  related  to 
sympathetically  mediated  seminal  emission.  Both  quinelorane 
(Experiment  1)  and  apomorphine  (7)  in  the  PVN  increased  the 
number of seminal emissions  in  supine,  restrained  male rats.  A 
similar  relationship  between  ex  copula  reflexes  and  copulatory 
measures  was  observed  with  manipulations  of dopamine  recep- 
tors in the MPOA, although low doses of quinelorane were inef- 
fective in the MPOA. 
Foreman and Hall also observed dose-related effects in copu- 
lation tests,  using  systemic  injections of quinelorane  (3).  Doses 
ranging from 25  ng/kg to 2.5  mg/kg enhanced ejaculatory mech- 
anisms  (decreased  ejaculation  latency  and  decreased  intromis- 
sions  preceding  ejaculation),  whereas  a  high  dose  (25  mg/ 
kg)increased  ejaculatory  latency  and  decreased  the  number  of 
animals  copulating.  None  of  our  doses  significantly  affected 
ejaculation  latency  or  number  of  animals  copulating,  but  all 
doses  decreased  intromissions  preceding  ejaculation.  However, 
it is difficult to compare dose-response  curves for systemic and 
intracranial injections. 
Another question  addressed  in  this  experiment  was  the  rela- 
tionship  of D1  and  D2 receptors  in the regulation  of genital re- 
sponses.  Melis  et  al.  (6)  reported  that  SCH-23390  blocked  the 
facilitative effects of apomorphine,  and inferred that endogenous 
dopamine  stimulation  of D1  receptors  enable  the  D2-mediated 
response.  Our data  also  show that  administration  of the  Dl  an- 
tagonist blocked the facilitation by  1  Ixg quinelorane  of intense 
erections and long penile movements. 
There  are  two possible  interpretations  of our data.  In  agree- 
ment with Melis et al.  (6),  the decrease in penile erections after 
administration  of the  D1  antagonist  may have resulted  from the 
loss of the enabling function of the D1  receptors.  An alternative 
interpretation  of the  data  suggests  that  D1  receptors  work  in an 
antagonistic  fashion  to  D2  receptors.  Thus  the  addition  of  the 
D1  antagonist  may  shift the potency of the D2 receptor agonist 
(quinelorane)  toward  that  of  higher  doses.  In  support  of  this 
view,  we  have  found  that  the  effectiveness of the  combination 
of 1 Ixg quinelorane plus  5  txg SCH-23390  was between that of 
the  1  ~g  and  10  Ixg doses  of quinelorane for intense erections, 
long penile  movements  and  seminal  emissions.  The  addition  of 
5  p~g  SCH-23390  to  the  ineffective dose  of  1  p,g  quinelorane 
resulted in a  significant increase  in seminal emission,  similar to 
that  of the  10  ixg  dose.  It  is possible  that  D1  receptor  stimula- 
tion  enables  erections  while  antagonizing  seminal  emission;  on D2 AGONIST IN PVN AND SEXUAL BEHAVIOR  181 
the other hand,  D1  receptor stimulation may antagonize all D2- 
mediated  effects  in  the  PVN.  Additional  experiments  will  be 
needed  to  clarify  this  relationship.  However,  it  is  of  interest 
that the  mixed  D1/D2  agonist  apomorphine  was  generally  less 
effective  in  Experiment  2  than  was  the  selective  D2  agonist 
quinelorane. 
In  summary,  the  present  data  support  a  biphasic  dose-re- 
sponse curve of quinelorane in the PVN on genital responses and 
copulation  in  the  male  rat.  A  low  dose  (1  I~g)  of quinelorane 
increased  the  numbers  of  intense  erections  and  long  penile 
movements and decreased  mount latency.  A  high dose  (10  p,g) 
reduced erections ex copula and delayed and slowed copulation. 
Both quinelorane (Experiment  1) and apomorphine (7) increased 
the number of seminal emissions ex copula and enhanced ejacu- 
latory ability in copula  (decreased intromissions preceding ejac- 
ulation). In addition, we suggest an alternative hypothesis for the 
interactions of D1  and D2 receptors regulating genital reponses. 
Melis and co-workers proposed that D1  receptors enable D2-me- 
diated effects  on genital responses  (6).  We,  on  the other hand, 
suggest that D1  receptors in the PVN,  as  well as in the MPOA, 
may be antagonistic to D2 receptors. 
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